Joseph (“Joeâ€) Amprey, M.D., Ph.D. Senior Managing Director, MedImmune Ventures, Inc.
Joe joined MedImmune in 2006 as a principal within MedImmune Ventures to assist in deal sourcing and portfolio management and became a Managing Director in 2007. He comes to MedImmune Ventures from Carrot Capital (CCHV) where he was responsible for deal sourcing and had operational roles within CCHV’s portfolio companies. Previously, Joe completed an internship in internal medicine at both New York–Presbyterian Hospital and Memorial Sloan-Kettering Cancer Center. During medical school, Joe was an independent consultant to Arch Venture Partners. He earned a bachelor’s degree in biochemistry from the University of Pennsylvania, and received both a doctorate in immunology and a medical degree from Cornell University’s Weill Medical College. Joe sits on the board of Synovex, Inc and is an observer on the boards of Ambit Biosciences, Inc, Elusys Therapeutics, Inc, and VLST, Inc.
